Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Assessment of early renal damage in diabetic rhesus monkeys.

Wang D, Liu J, He S, Wang C, Chen Y, Yang L, Liu F, Ren Y, Tian H, Yang G, Liao G, Li L, Shi M, Yuan Y, Zhao J, Cheng J, Lu Y.

Endocrine. 2014 Dec;47(3):783-92. doi: 10.1007/s12020-014-0211-4. Epub 2014 Mar 12.

PMID:
24619287
2.

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.

Gangadharan Komala M, Gross S, Zaky A, Pollock C, Panchapakesan U.

Nephrology (Carlton). 2016 May;21(5):423-31. doi: 10.1111/nep.12618.

PMID:
26375854
3.

Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.

Wang Y, Lin C, Ren Q, Liu Y, Yang X.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6828-34. eCollection 2015.

4.

Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.

Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, Bertram JF.

Diabetes. 2010 Oct;59(10):2612-24. doi: 10.2337/db09-1631. Epub 2010 Aug 3.

5.

Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.

Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ.

J Ethnopharmacol. 2011 Dec 8;138(3):731-6. doi: 10.1016/j.jep.2011.10.015. Epub 2011 Oct 19.

PMID:
22027446
6.

Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats.

Arya A, Yadav HN, Sharma PL.

Mol Cell Biochem. 2011 Aug;354(1-2):57-66. doi: 10.1007/s11010-011-0805-6. Epub 2011 Apr 6.

PMID:
21468648
7.

Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.

Zhao TT, Zhang HJ, Lu XG, Huang XR, Zhang WK, Wang H, Lan HY, Li P.

PLoS One. 2014 Mar 19;9(3):e90807. doi: 10.1371/journal.pone.0090807. eCollection 2014.

8.

Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.

Høj Thomsen L, Fog-Tonnesen M, Nielsen Fink L, Norlin J, de Vinuesa AG, Krarup Hansen T, de Heer E, Ten Dijke P, Rosendahl A.

Nephron. 2017;135(4):291-306. doi: 10.1159/000453337. Epub 2017 Jan 7.

PMID:
28064277
9.

BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.

Kolati SR, Kasala ER, Bodduluru LN, Mahareddy JR, Uppulapu SK, Gogoi R, Barua CC, Lahkar M.

Environ Toxicol Pharmacol. 2015 Mar;39(2):690-9. doi: 10.1016/j.etap.2015.01.019. Epub 2015 Feb 7.

PMID:
25704036
11.

[Effects of quercetin on nuclear factor-κB p65 expression in renal ubiquitin-proteasome system of diabetic rats].

Chen P, Chen JB, Chen WY, Zheng QL, Wang YQ, Xu XJ.

Zhonghua Nei Ke Za Zhi. 2012 Jun;51(6):460-5. Chinese.

PMID:
22943758
12.

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

Wang S, Denichilo M, Brubaker C, Hirschberg R.

Kidney Int. 2001 Jul;60(1):96-105.

13.

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.

Ding D, Du Y, Qiu Z, Yan S, Chen F, Wang M, Yang S, Zhou Y, Hu X, Deng Y, Wang S, Wang L, Zhang H, Wu H, Yu X, Zhou Z, Liao Y, Chen X.

J Mol Med (Berl). 2016 Feb;94(2):207-18. doi: 10.1007/s00109-015-1343-6. Epub 2015 Sep 26.

14.

Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.

Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM.

J Ethnopharmacol. 2015 Sep 15;173:256-65. doi: 10.1016/j.jep.2015.07.036. Epub 2015 Jul 28.

PMID:
26226437
15.

Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.

Kuo CW, Shen CJ, Tung YT, Chen HL, Chen YH, Chang WH, Cheng KC, Yang SH, Chen CM.

Life Sci. 2015 Aug 15;135:77-86. doi: 10.1016/j.lfs.2015.04.018. Epub 2015 May 23.

PMID:
26006040
16.

Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.

Gangadharan Komala M, Gross S, Mudaliar H, Huang C, Pegg K, Mather A, Shen S, Pollock CA, Panchapakesan U.

PLoS One. 2014 Nov 4;9(11):e108994. doi: 10.1371/journal.pone.0108994. eCollection 2014.

17.

Decrease of FGF receptor (FGFR) and interstitial fibrosis in the kidney of streptozotocin-induced diabetic rats.

Cheng MF, Chen LJ, Wang MC, Hsu CT, Cheng JT.

Horm Metab Res. 2014 Jan;46(1):1-7. doi: 10.1055/s-0033-1349090. Epub 2013 Jul 4.

PMID:
23828126
18.

Protective effects of calcitriol on diabetic nephropathy are mediated by down regulation of TGF-β1 and CIP4 in diabetic nephropathy rat.

Yu R, Mao J, Yang Y, Zhang Y, Tian Y, Zhu J.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3503-12. eCollection 2015.

19.

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.

Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA.

Chem Biol Interact. 2011 Jul 15;192(3):233-42. doi: 10.1016/j.cbi.2011.03.014. Epub 2011 Mar 30.

PMID:
21457706
20.

Kidney involvement in a nongenetic rat model of type 2 diabetes.

Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE.

Kidney Int. 2005 Dec;68(6):2562-71.

Supplemental Content

Support Center